{"id":"W4385779498","doi":"10.1007/s12325-023-02606-x","title":"Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis","year":2023,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Medicine; Crizotinib; Brain metastasis; Anaplastic lymphoma kinase; Internal medicine; Oncology; ALK inhibitor; Lung cancer; Interim analysis; Tyrosine-kinase inhibitor; Progression-free survival; Metastasis; Clinical trial; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006210397,0.0002334261,0.0003241724,0.0001767595,0.0001074442,0.00001517911,0.00004012016,0.00002225148,0.00003063127],"category_scores_gemma":[0.00001970369,0.0001347509,0.00006281159,0.000424265,0.00005127662,0.0002036224,0.000004101358,0.00004897427,0.00001934198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002451101,"about_ca_system_score_gemma":0.00008286082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006683231,"about_ca_topic_score_gemma":0.000309557,"domain_scores_codex":[0.9989559,0.00003313724,0.0001859345,0.0003389474,0.0002314158,0.000254667],"domain_scores_gemma":[0.9991869,0.0003315975,0.0001052964,0.0002014234,0.000102377,0.00007242568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02474118,0.00433391,0.02971336,0.00008704748,0.002205048,0.0001248306,0.004648366,0.008850162,0.00003923785,0.001887217,0.0001068611,0.9232628],"study_design_scores_gemma":[0.2670496,0.2927829,0.2178742,0.0027907,0.002754974,0.00006805299,0.003796372,0.002248838,0.007856101,0.008739949,0.1920419,0.001996386],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868813,0.001131232,0.00217736,0.003336103,0.0001211683,0.004407423,0.0003976797,0.0001186118,0.001429184],"genre_scores_gemma":[0.9886986,0.001931837,0.005160942,0.0007124997,0.00004884426,0.001529644,0.001001102,0.00005710043,0.0008594551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9212664,"threshold_uncertainty_score":0.5494982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02005702054535472,"score_gpt":0.364229775795692,"score_spread":0.3441727552503372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}